{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:18:10Z","timestamp":1790032690083,"version":"4.0.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.vaccine.2005.07.084","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T11:38:16Z","timestamp":1123846696000},"page":"221-228","source":"Crossref","is-referenced-by-count":45,"title":["Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?"],"prefix":"10.1016","volume":"24","author":[{"given":"Daniel M.","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ying C.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Schneerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.07.084_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/clinids\/5.1.71","article-title":"Meningococcal disease: still with us","volume":"5","author":"Peltola","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.196.5.388","article-title":"An epidemic in an Eskimo village due to group-B meningococcus. 2. Clinical features","volume":"196","author":"Corbett","year":"1966","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.07.084_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/00365548809032454","article-title":"An epidemic outbreak of group B meningococcal disease on the Faroe Islands","volume":"20","author":"Weihe","year":"1988","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib4","first-page":"819","article-title":"An outbreak of serogroup B:15:P1.16 meningococcal disease, Frederiksborg County, Denmark, 1987\u20139","volume":"10","author":"Samuelsson","year":"1992","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2005.07.084_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"W Silva. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1. 3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.084_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1440-1754.2001.00722.x","article-title":"A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991\u20132000","volume":"37","author":"Baker","year":"2001","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2005.07.084_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/00365549609027167","article-title":"Meningococcal disease in Norway 1992\u20131995. Epidemiology and fatality","volume":"28","author":"Iversen","year":"1996","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib8","first-page":"163","article-title":"Meningococcal meningitis in Spain (1985\u20131987) Evolution of the proteic subtypes within the serotypes 2 and 15 of Neisseria meningitidis during the epidemic wave","volume":"64","author":"Roman","year":"1990","journal-title":"Rev Sanid Hig Publica (Madr)"},{"key":"10.1016\/j.vaccine.2005.07.084_bib9","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.281.16.1493","article-title":"Epidemic serogroup B meningococcal disease in Oregon","volume":"281","author":"Diermayer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.07.084_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0950268898001848","article-title":"Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993\u20136","volume":"122","author":"Connolly","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2005.07.084_bib11","unstructured":"Control of epidemic meningococcal disease, in World Health Organization emerging and other communicable disease, surveillance and control, 2nd ed. WHO practical guidelines; 1997."},{"key":"10.1016\/j.vaccine.2005.07.084_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.084_bib13","first-page":"97","article-title":"Capsular polysaccharides as vaccine candidates","volume":"150","author":"Jennings","year":"1990","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib14","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.07.084_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1126\/science.451601","article-title":"Host defense against Neisseria meningitidis requires a complement-dependent bactericidal activity","volume":"205","author":"Nicholson","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.07.084_bib16","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/infdis\/155.6.1266","article-title":"Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals","volume":"155","author":"Ross","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1542\/peds.71.6.923","article-title":"Influence of age on serogroup distribution of endemic meningococcal disease","volume":"71","author":"Baker","year":"1983","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2005.07.084_bib18","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0021-9258(19)41784-5","article-title":"Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance","volume":"250","author":"Bhattacharjee","year":"1975","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2005.07.084_bib19","doi-asserted-by":"crossref","first-page":"8915","DOI":"10.1016\/S0021-9258(19)52486-3","article-title":"Lipid on capsular polysaccharides of Gram-negative bacteria","volume":"256","author":"Gotschlich","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2005.07.084_bib20","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM197405302902202","article-title":"Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis","volume":"290","author":"Robbins","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.07.084_bib21","first-page":"596","article-title":"Escherichia coli 0:H serotypes isolated from human blood. Prevalence of the K1 antigen with technical details of 0 and H antigenic determination","volume":"[B] 83","author":"\u00d8rskov","year":"1975","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.vaccine.2005.07.084_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0140-6736(77)92111-0","article-title":"Frequency of E. coli K antigens in urinary-tract infections in children","volume":"i","author":"Kaijser","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.084_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0022172400060678","article-title":"Escherichia coli in extra-intestinal infections","volume":"95","author":"\u00d8rskov","year":"1985","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2005.07.084_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1574-6968.1987.tb02293.x","article-title":"Production of coliminic acid by Pasteurella haemolytica serotype A2 organisms","volume":"42","author":"Adlam","year":"1987","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2005.07.084_bib25","first-page":"241","article-title":"Serotypes of Pasteurella haemolytica and Pasteurella trehalosi isolated from farm animals in Hungary","volume":"46","author":"Fodor","year":"1999","journal-title":"Zentralbl Veterinarmed B"},{"key":"10.1016\/j.vaccine.2005.07.084_bib26","first-page":"65","article-title":"Surface polysaccharide of Moraxella non-liquefaciens identical to Neisseria meningitidis group B capsular polysaccharide. A chemical and immunological investigation","volume":"6","author":"Bovre","year":"1983","journal-title":"NIPH Ann"},{"key":"10.1016\/j.vaccine.2005.07.084_bib27","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/IAI.59.2.732-736.1991","article-title":"Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated)","volume":"59","author":"Devi","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.084_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1126\/science.6823544","article-title":"Cell adhesion molecules","volume":"219","author":"Edelman","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.07.084_bib29","doi-asserted-by":"crossref","first-page":"11966","DOI":"10.1016\/S0021-9258(18)33661-5","article-title":"Occurrence of unique polysialosyl carbohydrate units in glycoproteins of developing brain","volume":"257","author":"Finne","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2005.07.084_bib30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0955-0674(96)80109-8","article-title":"Polysialic acid and the regulation of cell interactions","volume":"8","author":"Rutishauser","year":"1996","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0882-4010(86)90036-7","article-title":"Antibodies to the capsular polysaccharide of Neisseria meningitidis group B or E. coli K1 bind to the brains of infant rats in vitro but not in vivo","volume":"1","author":"Saukkonen","year":"1986","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2005.07.084_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1084\/jem.147.3.629","article-title":"Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specific of protection in a guinea pig model","volume":"147","author":"Frasch","year":"1978","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.07.084_bib33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1172\/JCI109383","article-title":"Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man","volume":"63","author":"Zollinger","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2005.07.084_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/IAI.43.1.407-412.1984","article-title":"Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis","volume":"43","author":"Jenning","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.084_bib35","first-page":"3566","article-title":"Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2 and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates","volume":"60","author":"Verheul","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.084_bib36","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1086\/368360","article-title":"Highly conserved Neisseria meningitidis inner-core lipopoysaccharide epitope confers protection against experimental meningococcal bacteremia","volume":"187","author":"Plested","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/IAI.65.1.55-63.1997","article-title":"Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically-diverse collection of serogroup B strains","volume":"65","author":"Rokbi","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.084_bib38","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nbt728","article-title":"Previously unrecognized vaccine candidates against group B meningococcus indentified by DNA microarrays","volume":"20","author":"Grifantini","year":"2002","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib39","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jama.276.14.1181","article-title":"Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b: impact on public health and implications for other polysaccharide-based vaccines","volume":"276","author":"Robbins","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.07.084_bib40","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1086\/340050","article-title":"Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland 1995\u20132000","volume":"34","author":"Healy","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib41","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/520303","article-title":"Complications and sequelae of meningococcal disease in Quebec, Canada 1990\u20131994","volume":"26","author":"Erickson","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib42","first-page":"861","article-title":"Association of meningococcal serogroups with the course of disease in the Netherlands 1959\u201383","volume":"65","author":"Spanjaard","year":"1987","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2005.07.084_bib43","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/00006454-199310000-00002","article-title":"Deafness, complement deficiencies and immunoglobulin status in patients with meningococcal diseases due to uncommon serogroups","volume":"12","author":"Mayatepek","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2005.07.084_bib44","first-page":"3","article-title":"Late sequelae after meningococcal disease. A controlled study in young men","volume":"7","author":"Sander","year":"1984","journal-title":"NIPH Ann"},{"key":"10.1016\/j.vaccine.2005.07.084_bib45","first-page":"23","article-title":"Meningococcal disease in the Norwegian Armed Forces 1967\u20131979. Some epidemiological aspects","volume":"3","author":"Berild","year":"1980","journal-title":"NIPH Ann"},{"key":"10.1016\/j.vaccine.2005.07.084_bib46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/JCM.10.3.302-307.1979","article-title":"Rapid serogroup identification of Neisseria meningitidis by using antiserum agar: Prevalence of serotypes in a disease-free military population","volume":"10","author":"Craven","year":"1979","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/inf.1978.10.issue-1.08","article-title":"Carriage of Neisseria meningitidis in a semi-isolated arctic community","volume":"10","author":"Holten","year":"1978","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1651-2227.1999.tb01094.x","article-title":"Nasopharyngeal carriage of meningococcus and meningococcal meningitis in Sokoto, Nigeria","volume":"88","author":"Emele","year":"1999","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2005.07.084_bib49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/S0950268801006173","article-title":"Prevalence of Neisseria meningitidis carriers in the school population of Catalonia, Spain","volume":"127","author":"Dominguez","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2005.07.084_bib50","series-title":"Enterobacteriaceae","author":"Kauffman","year":"1966"},{"key":"10.1016\/j.vaccine.2005.07.084_bib51","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/JB.100.2.730-737.1969","article-title":"Mouse virulence of K(L) antigen-containing strains of Escherichia coli","volume":"100","author":"Wolberg","year":"1969","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/infdis\/131.1.6","article-title":"The relation of K-antigen to virulence of Escherichia coli","volume":"131","author":"McCabe","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/IAI.16.1.75-80.1977","article-title":"Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1","volume":"16","author":"Glode","year":"1977","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.084_bib54","first-page":"299","article-title":"Avian pathogenic Escherichia coli (APEC)","volume":"30","author":"Dho-Moulin","year":"1999","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2005.07.084_bib55","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(75)92496-4","article-title":"Epidemiology of Escherichia coli K1 in healthy and diseased newborns","volume":"i","author":"Sarff","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.084_bib56","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunologic response of man to group B meningococcal polysaccharide vaccines","volume":"126","author":"Wyle","year":"1972","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib57","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/JCM.15.2.324-329.1982","article-title":"Identification of immunoglobulin heavy-chain isotypes of specific antibodies of horse 46 group B meningococcal antiserum","volume":"15","author":"Allen","year":"1982","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib58","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.147.3.619","article-title":"Protection against group B meningococcal disease. II. Infection and resulting immunity in a guinea pig model","volume":"147","author":"Frasch","year":"1978","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.07.084_bib59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0934-8840(97)80001-1","article-title":"The immune response to the capsular polysaccharide of Neisseria meningitidis group B","volume":"285","author":"Romero","year":"1997","journal-title":"Zentralbl Bakteriol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib60","doi-asserted-by":"crossref","first-page":"728u","DOI":"10.1093\/infdis\/137.6.728","article-title":"Safety and immunogenicity of a meningococcal type 2 protein vaccine in animals and human volunteers","volume":"137","author":"Zollinger","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib61","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/infdis\/158.4.710","article-title":"Antibody response of adults to an aluminium hydroxide adsorbed Neisseria meningitidis serotype 2b protein-Group B polysaccharide vaccine","volume":"158","author":"Frasch","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib62","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0264-410X(96)00001-1","article-title":"Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine","volume":"14","author":"Peeters","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.084_bib63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(84)91083-3","article-title":"Safety of vaccines containing meningococcal group B polysaccharide","volume":"2","author":"Zollinger","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.07.084_bib64","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0264-410X(91)90318-Z","article-title":"Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteins","volume":"9","author":"Lifely","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.084_bib65","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1073\/pnas.88.16.7175","article-title":"Antibodies to poly[(2\u20138)-alpha-N-acetylneuraminic acid] and poly[(2\u20139)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1","volume":"88","author":"Devi","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.07.084_bib66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0264-410X(94)00007-A","article-title":"Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide","volume":"13","author":"Bartoloni","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.084_bib67","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/IAI.65.3.1053-1060.1997","article-title":"Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines","volume":"65","author":"Zollinger","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.084_bib68","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4049\/jimmunol.137.5.1708","article-title":"Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine","volume":"137","author":"Jennings","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib69","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.vaccine.2003.10.005","article-title":"Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers","volume":"22","author":"Buge","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.084_bib70","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/infdis\/124.3.277","article-title":"Serologic studies of meningococcal infection and polysaccharide vaccination","volume":"124","author":"Artenstein","year":"1971","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib71","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4049\/jimmunol.108.4.913","article-title":"A radioactive antigen-binding assay for Neisseria meningitidis polysaccharide antibody","volume":"108","author":"Brandt","year":"1972","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib72","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/IAI.38.3.1203-1207.1982","article-title":"Class-specific antibody response to group B Neisseria meningitidis capsular polysaccharide: use of polylysine precoating in an enzyme-linked immunosorbent assay","volume":"38","author":"Leinonen","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.084_bib73","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.4049\/jimmunol.129.5.2172","article-title":"Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants","volume":"129","author":"Mandrell","year":"1982","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib74","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/149.3.387","article-title":"Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis","volume":"149","author":"Skevakis","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib75","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/00365548709117197","article-title":"Benign meningococcemia with IgG and IgM antimeningococcal antibodies measured by ELISA","volume":"19","author":"Flaegstad","year":"1987","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib76","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-3083.1992.tb03258.x","article-title":"Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy","volume":"35","author":"D\u2019Amelio","year":"1992","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib77","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/CDLI.4.3.345-351.1997","article-title":"Measurement of antibodies against meningococcal capsular polysaccharides B and C in enzyme-linked immunosorbent assays: towards an improved surveillance of meningococcal disease","volume":"4","author":"Andersen","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-5728(90)90146-E","article-title":"Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis","volume":"29","author":"Nedelec","year":"1990","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib79","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/CDLI.2.5.574-582.1995","article-title":"Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease","volume":"2","author":"Granoff","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib80","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.4049\/jimmunol.166.10.6250","article-title":"Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B","volume":"166","author":"Vidarsson","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib81","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1073\/pnas.82.4.1194","article-title":"NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci","volume":"82","author":"Frosch","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.07.084_bib82","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1084\/jem.164.2.642","article-title":"A human monoclonal macroglobulin with specificity for alpha(2\u20138)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA","volume":"164","author":"Kabat","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.07.084_bib83","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/IAI.63.5.1906-1913.1995","article-title":"Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain","volume":"63","author":"Azmi","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.084_bib84","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1083\/jcb.102.3.731","article-title":"Molecular forms of N-CAM and its RNA in developing and denervated skeletal muscle","volume":"102","author":"Covault","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib85","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1242\/dev.102.4.749","article-title":"Neural cell adhesion molecules during embryonic induction and development of the kidney","volume":"102","author":"Klein","year":"1988","journal-title":"Development"},{"key":"10.1016\/j.vaccine.2005.07.084_bib86","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/eji.1830190509","article-title":"Developmentally regulated expression of the neural cell adhesion molecule (NCAM) by mouse thymocytes","volume":"19","author":"Brunet","year":"1989","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib87","first-page":"424","article-title":"Overlapping expression of immunohistochemical markers and synaptophys in mRNA of pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors","volume":"72","author":"Komminoth","year":"1995","journal-title":"Lab Invest"},{"key":"10.1016\/j.vaccine.2005.07.084_bib88","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0166-2236(96)10041-2","article-title":"Polysialic acid in the vertebrate nervous system: a promoter of plasticity in cell\u2013cell interactions","volume":"19","author":"Rutishauser","year":"1996","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.vaccine.2005.07.084_bib89","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1523\/JNEUROSCI.17-13-05221.1997","article-title":"Role of neural cell adhesion molecule and polysialic acid in mouse circadian clock function","volume":"17","author":"Shen","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.vaccine.2005.07.084_bib90","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0161-5890(89)90003-5","article-title":"Interaction of meningococcal group B monoclonal antibody and its Fab fragment with alpha 2-8-linked sialic acid polymers: requirement of a long oligosaccharide segment for binding","volume":"26","author":"Hayrinen","year":"1989","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib91","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.138.12.4402","article-title":"An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues","volume":"138","author":"Finne","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib92","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1083\/jcb.103.6.2429","article-title":"A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N-CAM","volume":"103","author":"Rougon","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib93","first-page":"267","article-title":"Expression of polysiaic acid on human neuroblastoma","volume":"366","author":"Glick","year":"1991","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.vaccine.2005.07.084_bib94","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/infdis\/171.6.1481","article-title":"Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides","volume":"171","author":"Hayrinen","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.07.084_bib95","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.40.1.257-264.1983","article-title":"Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide","volume":"40","author":"Zollinger","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.07.084_bib96","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1574-6968.1981.tb07611.x","article-title":"Activation of complement by Neisseria meningitidis","volume":"12","author":"Di Ninno","year":"1981","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2005.07.084_bib97","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1056\/NEJM198007313030505","article-title":"Current concepts in immunology: the alternative pathway of complement\u2014a system for host resistance to microbial infection","volume":"303","author":"Fearon","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.07.084_bib98","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.134.4.2651","article-title":"Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis","volume":"134","author":"Jennings","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib99","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.168.2.699","article-title":"The epitope associated with the bonding of the capsular polysaccharide of the group B meningococcus and of Escherichia coli K1 in a human monoclonal macroglobulin, IgMNOV","volume":"168","author":"Kabat","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.07.084_bib100","doi-asserted-by":"crossref","first-page":"8399","DOI":"10.1021\/bi00399a055","article-title":"Conformational differences between linear \u03b1(2\u21928) linked homosialooligosaccharides and the epitope of group B meningococcal polysaccharide","volume":"26","author":"Michon","year":"1987","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2005.07.084_bib101","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0076-6879(03)01063-2","article-title":"Characterization of polysaccharide conformational epitopes by surface plasmon resonance","volume":"363","author":"MacKenzie","year":"2003","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2005.07.084_bib102","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/infdis\/157.1.118","article-title":"Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis Group B infections","volume":"157","author":"Raff","year":"1988","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05007681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:40:07Z","timestamp":1683175207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05007681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0264410X05007681"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}